Pitavastatin

Chemical formula: C₂₅H₂₄FNO₄  Molecular mass: 421.461 g/mol  PubChem compound: 5282452

Therapeutic indications

Pitavastatin is indicated for:

Primary hypercholesterolaemia, mixed dyslipidaemia

Population group: only adults (18 years old or older)

Pitavastatin is indicated for the reduction of elevated total cholesterol (TC) and LDL-C, in adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, and combined (mixed) dyslipidaemia, when response to diet and other non-pharmacological measures is inadequate.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Heterozygous familial hypercholesterolaemia

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Familial hypercholesterolaemia - heterozygous

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Pitavastatin is contraindicated in the following cases:

Lactation

Lactation

Pregnancy

Pregnancy

Myopathy

Disorder of muscle

Liver disease

Hepatopathy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: LIVAZO Film-coated tablet
Structured Product Labeling (SPL/PLR) 2019: LIVALO Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈